PL1851323T3 - Enzymatyczny sposób otrzymywania l-P-P z kappa kazeiny - Google Patents

Enzymatyczny sposób otrzymywania l-P-P z kappa kazeiny

Info

Publication number
PL1851323T3
PL1851323T3 PL06708461T PL06708461T PL1851323T3 PL 1851323 T3 PL1851323 T3 PL 1851323T3 PL 06708461 T PL06708461 T PL 06708461T PL 06708461 T PL06708461 T PL 06708461T PL 1851323 T3 PL1851323 T3 PL 1851323T3
Authority
PL
Poland
Prior art keywords
producing
enzymatic process
kappa casein
kappa
casein
Prior art date
Application number
PL06708461T
Other languages
English (en)
Inventor
Roos Andre Leonardus De
Den Broecke Pieter Marinus Van
Luppo Edens
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of PL1851323T3 publication Critical patent/PL1851323T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL06708461T 2005-02-24 2006-02-23 Enzymatyczny sposób otrzymywania l-P-P z kappa kazeiny PL1851323T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05101417 2005-02-24
EP05110236 2005-11-01

Publications (1)

Publication Number Publication Date
PL1851323T3 true PL1851323T3 (pl) 2017-02-28

Family

ID=36061583

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06708461T PL1851323T3 (pl) 2005-02-24 2006-02-23 Enzymatyczny sposób otrzymywania l-P-P z kappa kazeiny

Country Status (12)

Country Link
US (1) US8088597B2 (pl)
EP (1) EP1851323B1 (pl)
JP (1) JP5770411B2 (pl)
KR (1) KR101244995B1 (pl)
CN (2) CN103463615B (pl)
AU (1) AU2006217901B2 (pl)
BR (1) BRPI0608273B8 (pl)
EA (1) EA016396B1 (pl)
ES (1) ES2599859T3 (pl)
NZ (1) NZ560601A (pl)
PL (1) PL1851323T3 (pl)
WO (1) WO2006089921A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004098309A1 (en) 2003-05-05 2004-11-18 Unilever N.V. Hydrolysed casein product comprising tripeptides ipp and/ or vpp
EP1827477B1 (en) 2004-12-22 2015-10-21 DSM IP Assets B.V. Blood pressure lowering oligopeptides in a single enzymatic step
AU2006239560B2 (en) * 2005-04-28 2010-03-25 Unilever Plc Peptides having an ace inhibiting effect
WO2009057725A1 (ja) * 2007-10-31 2009-05-07 Ito En, Ltd. 蛋白質分解酵素処理モロヘイヤ抽出物組成物とその製造方法及び該組成物を含む血圧降下剤又は飲食物
NZ571856A (en) * 2008-10-09 2011-02-25 Fonterra Corporate Res And Dev Ltd Use of a phospholipid and ganglioside composition for the treatment or prevention of gout
AU2010334383B2 (en) * 2009-12-21 2014-10-02 Centre Hospitalier Universitaire Vaudois (Chuv) Synergic action of a prolyl protease and tripeptidyl proteases
CN107105709B (zh) * 2014-10-24 2021-04-30 杜邦营养生物科学有限公司 脯氨酸耐受性三肽基肽酶在饲料添加剂组合物中的用途
EP3397078A1 (en) 2015-12-28 2018-11-07 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
JP6993142B2 (ja) * 2017-08-31 2022-01-13 雪印メグミルク株式会社 アッカーマンシア・ムシニフィラ増加促進用組成物
JP6967404B2 (ja) * 2017-08-31 2021-11-17 雪印メグミルク株式会社 アッカーマンシア・ムシニフィラ増加促進用組成物
CN109380728B (zh) * 2018-10-17 2022-03-22 汤臣倍健股份有限公司 一种具有辅助降血压功效的组合物及保健食品
US11825860B1 (en) 2023-01-13 2023-11-28 Leprino Foods Company Denatured milk proteins and methods of making them

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3311051A1 (de) * 1983-03-25 1984-09-27 Siemens AG, 1000 Berlin und 8000 München Flexibles heizelement in bandform, das aus elektrisch leitfaehigen koernchen aus ptc-material und einem organischen isolierenden kunststoff als bindemittel besteht, und verfahren zur herstellung des flexiblen heizelementes
JP2622686B2 (ja) * 1987-05-15 1997-06-18 雪印乳業株式会社 ｋ−カゼイングリコマクロペプチドの製造法
JPH01291795A (ja) * 1988-05-18 1989-11-24 Takara Shuzo Co Ltd プロリン残基特異的ペプチダーゼの製造方法
JP2673828B2 (ja) * 1989-04-19 1997-11-05 雪印乳業株式会社 κ―カゼイングリコマクロペプチドの製造法
JP2920427B2 (ja) * 1991-01-21 1999-07-19 雪印乳業株式会社 κ−カゼイングリコマクロペプチドの製造法
DK8892D0 (da) * 1992-01-23 1992-01-23 Symbicom Ab Humant proteingen
US5391497A (en) * 1992-10-13 1995-02-21 University Of Colorado Foundation, Inc. Human k-casein
JPH06345664A (ja) * 1993-06-11 1994-12-20 Takako Tomita 新規な血圧上昇抑制用組成物
JP3567012B2 (ja) * 1995-03-28 2004-09-15 雪印乳業株式会社 新規ペプチド及びその利用
JPH09164A (ja) * 1995-06-22 1997-01-07 Asahi Chem Ind Co Ltd 加水分解蛋白質の製造方法
JPH1033115A (ja) * 1996-07-24 1998-02-10 Nouchikusangiyou Shinko Jigyodan ホエー飲料とその製造法
EP0963163A4 (en) * 1996-10-01 2004-09-08 Univ Massey PROCESS FOR ISOLATING GLYCOMACROPEPTIDE FROM DAIRY PRODUCTS, WITH A PHENYLALANINE IMPURE OF 0.5% BY WEIGHT
US6323008B1 (en) * 1997-08-14 2001-11-27 Neose Technologies, Inc. Methods for producing sialyloligosaccharides in a dairy source
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
US6168823B1 (en) * 1997-10-09 2001-01-02 Wisconsin Alumni Research Foundation Production of substantially pure kappa casein macropeptide
US5968586A (en) * 1997-10-09 1999-10-19 Wisconsin Alumni Research Foundation Production of κ-casein macropeptide for nutraceutical uses
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
JP4633876B2 (ja) * 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
DK1339837T3 (da) * 2000-12-07 2008-06-09 Dsm Ip Assets Bv Prolyl-endoprotease fra Aspergillus Niger
JP4815568B2 (ja) * 2001-01-05 2011-11-16 独立行政法人産業技術総合研究所 好熱性プロリルエンドペプチダーゼ
DE10149668A1 (de) * 2001-10-09 2003-04-10 Numico Res B V Insulinmimetische Aminosäuresequenzen
US20050256057A1 (en) * 2002-06-04 2005-11-17 Luppo Edens Protein hydrolysate rich in tripeptides
WO2004098309A1 (en) * 2003-05-05 2004-11-18 Unilever N.V. Hydrolysed casein product comprising tripeptides ipp and/ or vpp
DE602004017202D1 (de) * 2003-08-01 2008-11-27 Calpis Co Ltd Caseinhydrolysat, verfahren zur dessen herstellung sowie dessen verwendung
CA2558155A1 (en) * 2004-03-01 2005-09-09 Zvi Sidelman Casein derived peptides and therapeutic uses thereof
EA011865B1 (ru) * 2004-07-12 2009-06-30 ДСМ Ай Пи ЭССЕТС Б.В. Протеиновые гидролизаты, снижающие давление крови

Also Published As

Publication number Publication date
BRPI0608273A2 (pt) 2009-12-15
KR20070114141A (ko) 2007-11-29
CN101128596A (zh) 2008-02-20
KR101244995B1 (ko) 2013-03-18
EA016396B1 (ru) 2012-04-30
NZ560601A (en) 2009-09-25
AU2006217901B2 (en) 2011-09-29
US8088597B2 (en) 2012-01-03
EP1851323A1 (en) 2007-11-07
CN101128596B (zh) 2014-07-23
JP5770411B2 (ja) 2015-08-26
CN103463615B (zh) 2016-09-07
AU2006217901A1 (en) 2006-08-31
BRPI0608273B8 (pt) 2021-07-27
US20080161227A1 (en) 2008-07-03
EP1851323B1 (en) 2016-09-28
JP2008537476A (ja) 2008-09-18
WO2006089921A1 (en) 2006-08-31
CN103463615A (zh) 2013-12-25
BRPI0608273B1 (pt) 2017-04-04
ES2599859T3 (es) 2017-02-03
EA200701778A1 (ru) 2008-02-28

Similar Documents

Publication Publication Date Title
PL1851323T3 (pl) Enzymatyczny sposób otrzymywania l-P-P z kappa kazeiny
TWI349657B (en) Process for producing dichloropropanol
EP1974838A4 (en) METHOD FOR PRODUCING A PATTERN
IL184974A0 (en) Process for making (s)-pregabalin
MX280092B (es) Proceso para producir un compuesto de 5 - hidroxi - 4 - tiometilpirazol.
EP2119672A4 (en) HIGH-PURITY ALUMINUM MANUFACTURING METHOD
EP1861408A4 (en) PROCESS FOR PRODUCING HYDROCHLOROSILANES
HK1119152A1 (en) Process for producing nanocrystalline
EP1908999A4 (en) METHOD FOR MANUFACTURING METAL TRIM
ZA200804758B (en) Process for producing chemi-mechanical pulp
EP1874948A4 (en) PROCESS FOR THE PREPARATION OF Y-GLUTAMYLCYSTEIN
EP1939331A4 (en) METHOD FOR PRODUCING A COMPOSITE PLATED MATERIAL
GB0807808D0 (en) Process for the production of oligosaccharides
ZA200708208B (en) Process for producing cyclopropylphenol derivative
EP1862079A4 (en) PROCESS FOR PRODUCING SOY PROTEIN
EP1930484A4 (en) PROCESS FOR PRODUCING MONOCRYSTAL
IL215280A0 (en) Method for producing sulfonamides
EG25292A (en) Process for the production of anilines.
EP1930310A4 (en) PROCESS FOR PRODUCING 3,3,3-TRIFLUOROPROPIONALDEHYDE
SI3284458T1 (sl) Postopek izdelave pastil, ki vsebujejo nesteroidno protivnetno zdravilo
GB0501253D0 (en) Process for the production of olefins
IL180189A0 (en) Process for producing (z)-1-phenyl-1-diethylaminocarbonyl-2-hydroxymethylcyclopropane
EP1754738A4 (en) PROCESS FOR PREPARING POLYPYRIDINIUM
EP1907474A4 (en) PROCESS FOR PRODUCING A POLYOLEFIN
IL184221A0 (en) Process for the manufacture of taurine